Literature DB >> 20382715

Self-rated health predicts acute exacerbations and hospitalizations in patients with COPD.

Jerneja Farkas1, Mitja Kosnik, Matjaz Flezar, Stanislav Suskovic, Mitja Lainscak.   

Abstract

BACKGROUND: Self-rated health predicts outcome in chronic disease, but such information is scarce in COPD. We aimed to assess self-rated health as an outcome predictor in carefully characterized patients with this condition.
METHODS: This was a prospective study in 127 clinically stable patients with COPD (64 +/- 8 years, 79% men, 82% Global Initiative for Chronic Obstructive Lung Disease stage II or III). Self-rated health was assessed using a 5-grade Likert scale ranging from very poor to very good.
RESULTS: During 26.0 +/- 4.9 months of follow-up, 78 patients experienced acute exacerbation, 39 were hospitalized, and 10 died. Poor or very poor self-rated health was reported by 19 patients (15%) and was more common in patients experiencing acute exacerbations (20% vs 6%, P = .027) and hospitalizations (19% vs 5%, P = .039). Kaplan-Meier curves demonstrated more acute exacerbations (P = .003) and hospitalizations (P = .008) in patients with poor or very poor self-rated health. In a fully adjusted Cox model of proportional hazard, poor or very poor self-rated health remained predictive of acute exacerbations (hazard ratio [HR], 1.80; 95% CI, 1.03-3.11) and hospitalizations (HR, 1.93; 95% CI, 1.12-3.68) but not of death.
CONCLUSIONS: This study suggests that self-rated health is predictive of acute exacerbations and hospitalizations. Although prediction of mortality was limited, the study is supportive of self-rated health testing in COPD.

Entities:  

Mesh:

Year:  2010        PMID: 20382715     DOI: 10.1378/chest.09-2459

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  12 in total

1.  Use of complementary and alternative medicine and self-rated health status: results from a national survey.

Authors:  Long T Nguyen; Roger B Davis; Ted J Kaptchuk; Russell S Phillips
Journal:  J Gen Intern Med       Date:  2010-11-05       Impact factor: 5.128

2.  The prognostic performance of adding patient-reported outcomes to the MASCC risk index to identify low-risk febrile neutropenia patients with solid tumors and lymphomas.

Authors:  Xiao Jun Wang; Denise Yun Ting Goh; Sreemanee Raaj Dorajoo; Alexandre Chan
Journal:  Support Care Cancer       Date:  2017-04-11       Impact factor: 3.603

3.  Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Mitja Lainscak; Stephan von Haehling; Wolfram Doehner; Irena Sarc; Tina Jeric; Kristina Ziherl; Mitja Kosnik; Stefan D Anker; Stanislav Suskovic
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-03-01       Impact factor: 12.910

4.  Predictors of health status do not change over three-year periods and exacerbation makes difference in chronic obstructive pulmonary disease.

Authors:  Renata Ferrari; Suzana E Tanni; Laura M O Caram; Cristiane R Naves; Irma Godoy
Journal:  Health Qual Life Outcomes       Date:  2011-12-09       Impact factor: 3.186

5.  Reliability and validity of a single item measure of quality of life scale for adult patients with cystic fibrosis.

Authors:  Abebaw M Yohannes; Mary Dodd; Julie Morris; Kevin Webb
Journal:  Health Qual Life Outcomes       Date:  2011-11-25       Impact factor: 3.186

6.  Predictors of healthcare service utilization for mental health reasons.

Authors:  Marie-Josée Fleury; André Ngamini Ngui; Jean-Marie Bamvita; Guy Grenier; Jean Caron
Journal:  Int J Environ Res Public Health       Date:  2014-10-15       Impact factor: 3.390

7.  Clinical characteristics of asymptomatic left ventricular diastolic dysfunction and its association with self-rated health and N-terminal B-type natriuretic peptide: a cross-sectional study.

Authors:  Nasser S Ahmadi; Louise Bennet; Charlotte A Larsson; Susanne Andersson; Jörgen Månsson; Ulf Lindblad
Journal:  ESC Heart Fail       Date:  2016-04-01

8.  Efficacy and safety of AZD3199 vs formoterol in COPD: a randomized, double-blind study.

Authors:  Piotr Kuna; Yavor Ivanov; Vasily Ivanovich Trofimov; Takefumi Saito; Ola Beckman; Thomas Bengtsson; Carin Jorup; François Maltais
Journal:  Respir Res       Date:  2013-06-03

9.  Self-rated health and hospital services use in the Spanish National Health System: a longitudinal study.

Authors:  Nayara Tamayo-Fonseca; Andreu Nolasco; Jose A Quesada; Pamela Pereyra-Zamora; Inmaculada Melchor; Joaquin Moncho; Julia Calabuig; Carmen Barona
Journal:  BMC Health Serv Res       Date:  2015-11-04       Impact factor: 2.655

10.  Association of serum magnesium levels with frequency of acute exacerbations in chronic obstructive pulmonary disease: a prospective study.

Authors:  Aziz Gumus; Muge Haziroglu; Yilmaz Gunes
Journal:  Pulm Med       Date:  2014-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.